CI_with has_DoseForm has_Ingredient has_MoA has_PE may_treat drug associated with AE Drug Hypersensitivity [Disease/Finding] Hypotension [Disease/Finding] Subarachnoid Hemorrhage [Disease/Finding] Nimodipine [Chemical/Ingredient] Cerebral Arterial Vasodilation [PE] Coronary Arterial Vasodilation [PE] L-Calcium Channel Receptor Antagonists [MoA] [CV200] CALCIUM CHANNEL BLOCKERS Oral Capsule [Dose Form] NIMODIPINE NIMODIPINE 30MG CAP [VA Product] C0689771 Nimodipine 30 MG Oral Capsule NIMODIPINE CAP,ORAL 0 VA Product NIMODIPINE 30MG CAP 30 <Product_Component>NIMODIPINE</Product_Component><Strength>30</Strength><Unit>MG</Unit><VA.IEN>2003</VA.IEN> 尼莫地平胶丸 NIMODIPINE 30MG CAP <VANDF_Record>50.68^8154^Active/Master</VANDF_Record><VA_File>50.68</VA_File><VA_IEN>8154</VA_IEN><VA_Status>Active/Master</VA_Status> MG C47314 198037 尼莫地平胶囊 4008628 N0000156616 尼莫地平缓释胶囊 flushing AE hot flushes AE hepatitis AE headache AE asthenia AE dizziness AE edema limbs AE gastrointestinal hemorrhage AE hyperkinesia AE depression AE hypotension AE increased heart rate AE increased lactate dehydrogenase level AE vomiting AE stomach discomfort AE blood alkaline phosphatase increased AE blood glucose level increased AE feeling hot AE pain of skin AE thrombocytopenia AE platelet count increased AE transient dizzy AE NIMODIPINE 30MG CAP [VA Product] N0000156616 4008628 MG VA Product C0689771 C47314 198037 NIMODIPINE 30MG CAP Nimodipine 30 MG Oral Capsule NIMODIPINE CAP,ORAL 30 <Product_Component>NIMODIPINE</Product_Component><Strength>30</Strength><Unit>MG</Unit><VA.IEN>2003</VA.IEN> 尼莫地平胶丸 0 尼莫地平缓释胶囊 NIMODIPINE 30MG CAP 尼莫地平胶囊 <VANDF_Record>50.68^8154^Active/Master</VANDF_Record><VA_File>50.68</VA_File><VA_IEN>8154</VA_IEN><VA_Status>Active/Master</VA_Status>